Winter-2007
We have updated important
new medication safety information on CEFTRIAXONE SODIUM, as
reported by the
U.S. Food and Drug Administration.
We have added stability and compatibility
information for one new drug product: CELLCEPT®. Also included is compatibility information for CASPOFUNGIN
ACETATE, ALFENTANIL HYDROCHLORIDE, and CEFTAZIDIME in combination with numerous
other parenteral drugs.
Fall-2007
We have added important new medication safety
information on CEFTRIAXONE SODIUM, as reported by the
U.S.
Food and Drug Administration.
We have also added stability and
compatibility information for three new drug products: ARIPIPRAZOLE,
CASPOFUNGIN ACETATE, and ROPIVACAINE HYDROCHLORIDE. Also
included in this update are compatibility information for CEFEPIME,
GANCICLOVIR, KETAMINE, KETOROLAC, and NESIRITIDE.
Summer-2007
We have added compatibility information for one new drug product:
OXALIPLATIN. Included in this new drug monograph is compatibility
information for over 50 different parenteral drug combinations,
including: Bumetanide, Docetaxel, Dolasetron Mesylate, Enalaprilat,
Gemcitabine Hydrochloride, Leucovorin Calcium, Ondansetron
Hydrochloride, Paclitaxel, Ranitidine Hydrochloride, Topotecan
Hydrochloride, and Verapamil Hydrochloride. The results of
stability studies on PALONOSETRON HYDROCHLORIDE with
CISPLATIN, CARBOPLATIN, METOCLOPRAMIDE HYDROCHLORIDE,
and PROMETHAZINE HYDROCHLORIDE are also included in our 2007 Summer
Supplement.
Spring-2007
We have added compatibility
information for two new drug products: Piperacillin and Tazobactam
, and Pemetrexed. Included in these two new drug
monographs are compatibility information for over 80 different
parenteral drug combinations, including: amifostine, amikacin,
aztreonam, carboplatin, ciprofloxacin, dexrazoxane, docetaxel,
doxorubicin, gentamicin, granisetron, irinotecan, ranitidine,
topotecan, and zidovudine.
Winter-2006
We have added compatibility information for two new drugs:
Nesiritide in combination with 30 different drugs, and infusion
stability data for Insulin Aspart. In addition we have
provided additional information for these existing drug monographs:
Oxytocin, Palonosetron, Dacarbazine,
Cefuroxime, and Leucovorin Calcium.
Fall-2006
We have added compatibility
information for Lansoprazole in combination with seventy-eight different
parenteral products including the following: Acyclovir, Gemcitabine,
Alatrofloxacin, Gentamicin, Ceftriaxone, Labetalol, Cyclosporine, Midazolam,
Droperidol, Morphine, Enalaprilat, Nicardipine, Etoposide, Paclitaxel,
Famotidine, Ranitidine, Fentanyl, Vinorelbine, Ganciclovir, and Zidovudine.
Summer-2006
We have added compatibility
information for a new drug, Lansoprazole. Also included are new data
on the compatibility and stability of these drugs: Clonidine Hydrochloride,
Fentanyl Citrate, Morphine Sulfate, Hydralazine Hydrochloride, and
Vasopressin.
Spring-2006
We have added a new drug monograph,
DEXMEDETOMIDINE HYDROCHLORIDE (PRECEDEX®), in this supplement. Over 90
different drugs were tested with this drug, including: Alfentanil,
Amiodarone, Azithromycin, Aztreonam, Bretylium, Cefepime, Cimetidine,
Dobutamine, Dolasetron, Enalaprilat, Esmolol, Famotidine, Gatifloxacin,
Inamrinone, Ketorolac, Linezolid, Milrinone, Ofloxacin, Ondansetron,
Propofol, Ranitidine, Sufentanil, Vancomycin, and Verapamil.
Winter-2005
We have added a new drug monograph, Tramadol
Hydrochloride, in this supplement. Also included is new
information for 46 different drugs including entries for these parenteral
products: Argatroban, Cidofovir, Clonidine Hydrochloride, Dolasetron
Mesylate, Doxorubicin Hydrochloride, Droperidol, Fentanyl Citrate,
Gentamicin Sulfate, Ketamine Hydrochloride, Ketorolac Tromethamine,
Levofloxacin, Lorazepam, Morphine Sulfate, Ondandestron Hydrochloride,
Palonosetron Hydrochloride, Vancomycin Hydrochloride, and Zidovudine.
Fall-2005
Included in this supplement are new information for
Bivalirudin, Fenoldopam Mesylate, and Teniposide in combination with dozens
of other parenteral drug products. In addition, we have added
monographs for Codeine Sulfate, Ammonium Chloride, and Amobarbital.
Summer-2005
Included in this Supplement are compatibility data for one new drug
monograph, Drotrecogin Alfa, in combination with thirty-four different
parenteral medications. Also included are compatibility data for
Argatroban in combination with total parenteral nutrition solutions and with
these drugs: Amiodarone hydrochloride, Furosemide, Fenoldopam Mesylate,
Lidocaine Hydrochloride, Milrinone Lactate, Nitroglycerin, Nitroprusside
Sodium, and Vasopressin.
Spring-2005
Included in this Supplement are compatibility data for two new drug
monographs: Daptomycin and Palonosetron Hydrochloride. In addition we
have added new information to these existing monographs: Co-Trimoxazole,
Fluorouracil, Furosemide, Inamrinone Lactate, Levofloxacin, Nitroglycerin,
Norepinephrine Bitartrate, Ondansetron Hydrochloride, and Potassium
Phosphate.
Winter-2004
Included in this Supplement is new compatibility data for the following six
drugs: DOXORUBICIN HYDROCHLORIDE, NITROPRUSSIDE, DOCETAXEL, HETASTARCH,
TOTAL PARENTERAL NUTRITION SOLUTIONS, and BIVALIRUDIN. In
addition, this update includes update pages to transfer two drugs to their
current name: AMRINONE LACTATE is now INAMRINONE LACTATE and TRIMETHOPRIM
SULFAMETHOXAZOLE is now CO-TRIMOXAZOLE.
Fall-2004
Included in this Supplement are compatibility data for five new drug
monographs: Irinotecan Hydrochloride, Quinupristin and Dalfopristin,
Reteplase, Streptokinase, and Anti-Thymocyte Globulin (Rabbit). In
addition we have added new information to these existing monographs:
Fenoldopam Mesylate, Bivalirudin, Enoxaparin Sodium, Phenylephrine
Hydrochloride, and Eptifibatide.
Summer-2004
Included in this Supplement are compatibility data for four new drugs:
Fenoldopam Mesylate (Corlopam®), Ertapenem (Invanz®), Epoprostenol Sodium (Flolan®),
and Treprostinil Sodium (Remodulin®). In addition we have added new
information to these existing monographs: Cefepime Hydrochloride,
Cyclophosphamide, Dobutamine Hydrochloride, Mesna, Oxytocin, and Zidovudine.
Spring-2004
Included in this Supplement are compatibility data for Bivalirudin (Angiomax)
with 96 other drugs.
Winter 2003
Included in this supplement are compatibility data for Vasopressin with
these twelve different medications. Amiodarone, Lidocaine,
Diltiazem, Milrinone, Dobutamine, Nitroglycerin, Dopamine, Norepinephrine,
Epinephrine, Phenylephrine, Heparin, and Procainamide. In addition we
have added the results of the physical compatibility of parenteral nutrition
solutions with several several trace elements and other additives.
Fall 2003
Included in this Supplement are compatibility data for two new drug
monographs, ARGATROBAN and DOXAPRAM. In addition, new information has
been included for these existing monographs: Alcohol, Dacarbazine,
Dexamethasone, Furosemide, Glycopyrrolate, Imipenem-Cilastatin, and
Tenecteplase.
Spring 2003
Included in this Supplement are compatibility data for a new monograph
for Hetastarch in Lactated Electrolyte Injection in combination with 100
other parenteral drugs. These data have also been added to the
existing monographs for these 100 drugs.
Winter 2002
Included in this Supplement are compatibility data for these new drugs:
Dihydroergotamine Mesylate, Tenecteplase, and Eptifibatide. In
addition, new data have been added to the existing monographs for the
following drugs: Abciximab, Alteplase, Amikacin, Amiodarone,
Azithromycin, Aztreonam, Cefazolin, Cefotaxime, Ceftazidime, Ceftriaxone,
Ciprofloxacin, Diltiazem, Diphenhydramine, Dobutamine, Dopamine, Dolasetron,
Droperidol, Fentanyl, Furosemide, Gentamicin, Heparin, Imipenem-Cilastatin,
Ketamine, Ketorolac, Labetalol, Levofloxacin, Lidocaine, Linezolid,
Meperidine, Metoclopramide, Methylprednisolone, Metoprolol, Midazolam,
Morphine, Nafcillin, Nitroglycerin, Ondansetron, Piperacillin-tazobactam,
Potassium Chloride, Promethazine, Ticarcillin-Clavulanate, Tirofiban,
Tobramycin, Total Parenteral Nutrition, Trimethoprim-Sulfamethoxazole, and
Verapamil.
Fall 2002
The monograph for AMIODARONE has been expanded with the addition of
admixture compatibility for 38 drugs. In addition, new data have been
added to the existing monographs for the following drugs: Ampicillin Sodium,
Baclofen, Bupivacaine Hydrochloride, Cisplatin, Clonidine Hydrochloride,
Dexamethasone Sodium Phosphate, Doxorubicin Hydrochloride, Fentanyl Citrate,
Lidocaine Hydrochloride, Mitomycin, Morphine Sulfate, Nafcillin Sodium,
Oxacillin Sodium, Sufentanil Citrate, Verapamil Hydrochloride, Vincristine
Sulfate.
Summer 2002
New drug monographs are included for : Abciximab, Alprostadil, and
Morphine Hydrochloride. New data have been added to the existing
monographs for over 60 drugs, including: Acyclovir, Cefotaxime,
Ciprofloxacin, Dexamethasone, Docetaxel, Droperidol, Fentanyl, Foscarnet,
Ganciclovir, Levofloxacin, Lidocaine, Lorazepam, Metoclopramide, Midazolam,
Ranitidine, Tirofiban, Topotecan, and Vancomycin.
Spring 2002
With this supplement we have completed the updating of pH information
that subscribers may use to help decide on the acid/base stability of
parenteral admixtures. New pH stability information has been included for
over 100 drug monographs.
Winter 2001
Included in our Winter 2001 supplement is a new monograph of
compatibility information for CLARITHROMYCIN. Also included in the enclosed
supplement are additional compatibility data to the existing monographs for:
Carmustine
Cefepime Hydrochloride
Etoposide Phosphate
Doxorubicin Hydrochloride
Nitroprusside Sodium
Tirofiban Hydrochloride
Topotecan Hydrochloride
Vincristine Sulfate
In addition, and at the request of subscribers, we have provided updated
information on pH for over 50 drug monographs.
Fall 2001
Included in the enclosed supplement are compatibility data for a new
drug monograph, LINEZOLID. Research reports on linezolid in combination with
over 100 different parenteral drugs comprise the entire Fall Supplement.
Summer 2001
Included in our Summer 2001 Supplement are new compatibility data in the
monographs for these drugs:
Acyclovir Sodium
Alfentanil Hydrochloride
Carboplatin
Cefuroxime
Cisplatin
Cladribine
Methylprednisolone Sodium Succinate
Midazolam Hydrochloride
Nafcillin Sodium
Potassium Phosphate
Sufentanil
Total Parenteral Nutrition Solutions
Spring 2001
Included in our Spring 2001 Supplement, are data
on one new drug: SUMATRIPTAN SUCCINATE. In addition new
compatibility data for ALATROFLOXACIN, ALTEPLASE, AZTREONAM, CEFAZOLIN,
CEFEPIME, CEFOXITIN, CEFTAZIDIME, CEFTRIAXONE, CEPHALOTHIN, CIPROFLOXACIN,
GENTAMICIN, HEPARIN, KETAMINE, MORPHINE, RANITIDINE, AND VANCOMYCIN have
been added to their respective drug monographs.
Winter 2000
Included in our Winter 2000 Supplement, are data on these new drugs:
ALLOPURINOL SODIUM, DOLASETRON MESYLATE, DANAPAROID SODIUM, and VALPROATE
SODIUM. In addition new compatibility data for BACLOFEN, BUPIVACAINE,
CLONIDINE, DOBUTAMINE, FENTANYL,and TORSEMIDE have been added to their
respective drug monographs.
Fall 2000
Included in our Fall 2000 Supplement, are data on these new drugs:
DALTEPARIN, OXYCODONE, and SOMATROPIN (rDNA). In addition new
compatibility data for DOCETAXEL, ETOPOSIDE, GENTAMICIN, MEROPENEM,
NALBUPHINE, NITROPRUSSIDE , and PROPAFENONE have been added to their
respective drug monographs. Because of the change in the official name
of AMRINONE to INAMRINONE, we have included compatibility information in the
drug monographs under each name.
